• Users Online: 165
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2019| January-March  | Volume 2 | Issue 1  
    Online since April 1, 2019

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
REVIEWS
Gamma-delta T cells in glioblastoma immunotherapy
Sadhak Sengupta
January-March 2019, 2(1):30-36
DOI:10.4103/glioma.glioma_48_18  
  7,666 756 2
Combination of oncolytic viruses and immune checkpoint inhibitors in glioblastoma
Kunal Desai, Anne Hubben, Manmeet Ahluwalia
January-March 2019, 2(1):7-19
DOI:10.4103/glioma.glioma_5_19  
  6,617 503 2
Immune checkpoint modulation: Tenets and implications in glioblastoma
John P Lynes, Victoria E Sanchez, Anthony K Nwankwo, Gifty A Dominah, Edjah K Nduom
January-March 2019, 2(1):20-29
DOI:10.4103/glioma.glioma_47_18  
  5,419 375 -
Importance of iatrogenic immunosuppression in the treatment of patients with high-grade glioma with immunotherapy
Anna F Piotrowski, Stuart A Grossman
January-March 2019, 2(1):3-6
DOI:10.4103/glioma.glioma_8_19  
  4,339 317 -
CASE REPORT
Diffuse midline glioma, H3-K27M mutant: Awareness leads to identification
Sadhana Tiwari, Ishita Pant, Sujata Chaturvedi, Gurbachan Singh
January-March 2019, 2(1):55-59
DOI:10.4103/glioma.glioma_1_19  
  4,311 296 1
EDITORIAL
Glioma special issue introduction
Christopher Jackson, Michael Lim
January-March 2019, 2(1):1-2
DOI:10.4103/glioma.glioma_2_19  
  3,479 329 1
ORIGINAL ARTICLES
Evidence of calcium-activated potassium channel subunit alpha-1 as a key promoter of glioma growth and tumorigenicity
Divya Khaitan, Nagendra Ningaraj
January-March 2019, 2(1):46-54
DOI:10.4103/glioma.glioma_44_18  
  3,308 236 2
IDH1 mutation decreases the invasiveness of glioma by downregulating the expression and activity of TAZ
Ningning Li, Rui Zhang, Yi Sun, Chenyue Xu, Yin Wang, Ji Xiong, Qi Chen, Ying Liu
January-March 2019, 2(1):37-45
DOI:10.4103/glioma.glioma_46_18  
  3,285 258 1